S.C. Ropharma S.A. (BVB:RPH)
Romania · Delayed Price · Currency is RON 0.2220
+0.0020 (0.91%)
At close: Sep 1, 2026
S.C. Ropharma Financials Overview
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,662 | 1,538 | 1,323 | 1,120 | 1,002 | 888.16 |
Revenue Growth | 15.80% | 16.23% | 18.12% | 11.80% | 12.81% | 10.21% |
Gross Profit Gross Profit Growth | 326.35 | 323.16 | 292.79 | 254.14 | 213.88 | 201.23 |
Operating Income Operating Income Growth | 17.13 | 25.89 | 24.42 | 20.02 | 9.26 | 17.11 |
Net Income Net Income Growth | 8.11 | 2.18 | -1.73 | 7.72 | 9.22 | 10.73 |
Earnings Per Share EPS Growth | 0.02 | 0.00 | -0.00 | 0.02 | 0.02 | 0.02 |
EPS Growth | 3328.14% | - | - | -16.25% | -14.11% | 58.38% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Own Pharmacies Own Pharmacies Growth | 852.26 | 743.63 | 602.01 | 543.2 | 462.37 |
Distribution Distribution Growth | 548.41 | 455.31 | 409.75 | 369.54 | 314.31 |
Medical Services Medical Services Growth | 143.75 | 127.99 | 110.65 | 87.44 | 110.05 |
Total Total Growth | 1,544 | 1,327 | 1,122 | 1,000 | 886.74 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 46.72 | 58.13 | 19.9 | 16.51 | 15.42 | 10.66 |
Total Debt Total Debt Growth | 174.83 | 169.2 | 162.42 | 164.08 | 148.28 | 136.79 |
Net Cash (Debt) Net Cash Growth | -128.11 | -111.07 | -142.52 | -147.57 | -132.86 | -126.13 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.27 | -0.22 | -0.28 | -0.29 | -0.26 | -0.25 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 51.5 | 72.83 | 43.16 | 40.49 | 29.94 | 38.72 |
Capital Expenditures CapEx Growth | -11.38 | -15.43 | -10.87 | -13.59 | -10.43 | -17.19 |
Free Cash Flow Free Cash Flow Growth | 40.11 | 57.4 | 32.29 | 26.9 | 19.5 | 21.53 |
Free Cash Flow Growth | 131.46% | 77.77% | 20.06% | 37.90% | -9.41% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.63% | 21.01% | 22.13% | 22.69% | 21.35% | 22.66% |
Operating Margin | 1.03% | 1.68% | 1.85% | 1.79% | 0.92% | 1.93% |
Pretax Margin | 1.38% | 1.44% | 1.63% | 1.22% | 1.03% | 1.52% |
Profit Margin | 0.49% | 0.14% | -0.13% | 0.69% | 0.92% | 1.21% |
FCF Margin | 2.41% | 3.73% | 2.44% | 2.40% | 1.95% | 2.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.11 | 42.19 | - | 13.25 | 10.38 | 9.88 |
Forward PE | - | 15.42 | 15.42 | 15.42 | 15.42 | 15.42 |
P/FCF Ratio | 2.83 | 1.60 | 2.55 | 3.80 | 4.90 | 4.93 |
PS Ratio | 0.07 | 0.06 | 0.06 | 0.09 | 0.10 | 0.12 |